InvestorsHub Logo
Followers 57
Posts 2642
Boards Moderated 0
Alias Born 08/14/2019

Re: None

Friday, 10/09/2020 10:33:40 AM

Friday, October 09, 2020 10:33:40 AM

Post# of 44092
$CTYX here's why this is so huge:

IMT504 has been granted orphan drug status & qualifies for FDA Tropical Disease Priority Review Voucher (PRV) Program.

In 2016–2018, the value of a voucher ranged from $125 million to $200 million.

http://www.globenewswire.com/news-release/2020/10/09/2106348/0/en/Connectyx-Technologies-Holdings-Group-Inc-Announces-Definitive-Agreement-with-Mid-Atlantic-BioTherapeutics-Inc-for-Treatment-of-Symptomatic-Rabies.html